Scott Bizily
Fortune : 114 606 $ au 30/06/2026
Fortune : 114 606 $ au 30/06/2026
Scott P.
Bizily is Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. since 2024.
Dr. Bizily was General Counsel at Synthego Corp.
from 2019 to 2021.
Dr. Bizily was Director-Corporate Counsel at BioMarin Pharmaceutical, Inc. Dr. Bizily worked at Princeton University from 1991 to 1994.
Dr. Bizily earned a doctorate from the University of Georgia in 2001 and a graduate degree from the University of Pennsylvania in 2005.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2026 | 8 617 ( 0,02 % ) | 114 606 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Compliance Officer | 01/12/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Conseiller Juridique Général | 01/09/2021 |
| BIOMARIN PHARMACEUTICAL INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Engages in research, development and manufactures CRISPR cell & gene therapies | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national